Subscribe To
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm
Xenon pharmaceuticals announces pricing of $300.0 million public offering
BURNABY, British Columbia, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, tod...
October 5, 2021, 9:54 pm